These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1552353)

  • 1. Use of technetium-99m-MIBI in peripheral vascular disease.
    Segall GM
    J Nucl Med; 1992 Apr; 33(4):629. PubMed ID: 1552353
    [No Abstract]   [Full Text] [Related]  

  • 2. Leg muscle scintigraphy with 99Tcm-MIBI in the assessment of peripheral vascular (arterial) disease.
    Miles KA; Barber RW; Wraight EP; Cooper M; Appleton DS
    Nucl Med Commun; 1992 Aug; 13(8):593-603. PubMed ID: 1513521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle perfusion with technetium-MIBI in lower extremity peripheral arterial diseases.
    Sayman HB; Urgancioglu I
    J Nucl Med; 1991 Sep; 32(9):1700-3. PubMed ID: 1880572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m-MIBI scintigraphy in evaluating the effect of hepatocyte growth factor gene therapy for peripheral arteriosclerosis obliterans.
    Yamagami T; Kanda K; Okuyama C; Nishimura T
    Ann Nucl Med; 2009 Feb; 23(2):205-8. PubMed ID: 19225945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of leg perfusion during exercise using technetium 99m sestamibi. A new test for peripheral vascular disease.
    Wann LS; Hellman C; Dorros G
    Echocardiography; 1992 Sep; 9(5):547-52. PubMed ID: 10147794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty meal in 99Tcm-MIBI myocardial imaging.
    Hacking JC; Barber RW; Wraight EP
    Nucl Med Commun; 1991 Jun; 12(6):564. PubMed ID: 1866110
    [No Abstract]   [Full Text] [Related]  

  • 7. Visualization of suppressed thyroid tissue by Tc-99m MIBI.
    Kao CH; Lin WY; Wang SJ; Yeh SH
    Clin Nucl Med; 1991 Nov; 16(11):812-4. PubMed ID: 1752089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of TI-201 and Tc-99m MIBI in a patient with an apical aneurysm.
    Pace L; Cuocolo A; Salvatore M
    Clin Nucl Med; 1992 Apr; 17(4):325-7. PubMed ID: 1572126
    [No Abstract]   [Full Text] [Related]  

  • 9. Tc-99m MIBI uptake in the sternum.
    Lee JD; Kim SM; Park CH
    Clin Nucl Med; 1992 Oct; 17(10):819. PubMed ID: 1424362
    [No Abstract]   [Full Text] [Related]  

  • 10. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis.
    Aktolun C; Demirel D; Kir M; Bayhan H; Maden HA
    J Nucl Med; 1991 Jul; 32(7):1429-31. PubMed ID: 2066801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report.
    O'Driscoll CM; Baker F; Casey MJ; Duffy GJ
    J Nucl Med; 1991 Dec; 32(12):2281-3. PubMed ID: 1744716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dipyridamole Tc-99m MIBI myocardial perfusion scintigraphy in patients with post-infarction chest pain symptom].
    Yang CC; Wu CC; Jong SB
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):605-17. PubMed ID: 1296041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.
    Caner B; Kitapçi M; Aras T; Erbengi G; Uğur O; Bekdik C
    J Nucl Med; 1991 Oct; 32(10):1977-8. PubMed ID: 1919741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.
    Scott AM; Kostakoglu L; O'Brien JP; Straus DJ; Abdel-Dayem HM; Larson SM
    J Nucl Med; 1992 Jul; 33(7):1396-8. PubMed ID: 1613584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphy of the heart--a new generation of radiopharmaceutical agents, Technetium 99m-labeled isonitrile compounds].
    Wasilewski J; Pasyk S
    Kardiol Pol; 1991; 34(1):33-8. PubMed ID: 2051711
    [No Abstract]   [Full Text] [Related]  

  • 16. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 17. Noncardiac applications of hexakis(alkylisonitrile) technetium-99m complexes.
    Piwnica-Worms D; Holman BL
    J Nucl Med; 1990 Jul; 31(7):1166-7. PubMed ID: 2362196
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased accumulation of Tc-99m MIBI in undifferentiated mesenchymal tumor and its metastatic lung lesions.
    Caner B; Kitapci M; Erbengi G; Gögus T; Bekdik C
    Clin Nucl Med; 1992 Feb; 17(2):144-5. PubMed ID: 1563188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy].
    Leoncini M; Sciagrà R; Bisi G; Santoro GM; Fazzini PF
    G Ital Cardiol; 1993 Feb; 23(2):127-38. PubMed ID: 8491353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models in radiotracer design of a Tc-labelled myocardial perfusion imaging agent.
    Mousa SA
    Am J Physiol Imaging; 1991; 6(1):16-25. PubMed ID: 1828162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.